Lisata Therapeutics to Present at the GCFF Innovation and Healthcare Virtual Conference
12 6월 2023 - 9:30PM
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the
“Company”), a clinical-stage pharmaceutical company developing
innovative therapies for the treatment of advanced solid tumors and
other serious diseases, announces its participation in the upcoming
GCFF Innovation & Healthcare virtual conference on June 15,
2023.
David J. Mazzo, PhD, Chief Executive Officer of Lisata, will
present a company overview on Thursday, June 15th at 9:30am Pacific
time (12:30pm Eastern time). A live webcast of Dr. Mazzo’s
presentation will be available on the event website. For more
information about the GCFF virtual conference, including
registration details, please visit
https://nai500.com/events/gcff-virtual-conference-2023-investing-in-innovation-life-science-technology/.
About Lisata Therapeutics
Lisata Therapeutics is a clinical-stage pharmaceutical company
dedicated to the discovery, development and commercialization of
innovative therapies for the treatment of advanced solid tumors and
other major diseases. Lisata’s lead product candidate, LSTA1, is an
investigational drug designed to activate a novel uptake pathway
that allows co-administered or tethered anti-cancer drugs to target
and penetrate solid tumors more effectively. Based on Lisata’s
CendR Platform® Technology, Lisata has already established
noteworthy commercial and R&D partnerships. The company
projects the announcement of many clinical study and business
milestones over the next 2 years, having indicated that its current
business and development plan is funded with available capital
through these milestones and into early 2026. For more information
on the Company, please visit www.lisata.com.
Contact:
Investors and Media:
Lisata Therapeutics, Inc.John MendittoVice President, Investor
Relations and Corporate
CommunicationsPhone: 908-842-0084Email: jmenditto@lisata.com
Lisata Therapeutics (NASDAQ:LSTA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Lisata Therapeutics (NASDAQ:LSTA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024